Asia Pacific Hyperphosphatemia Drug Market Forecast 2019-2027

Publisher Name :
Date: 19-Nov-2018
No. of pages: 70

Key Findings

The Asia-Pacific hyperphosphatemia drugs market was worth $xx million in 2018. The market is estimated to grow at a CAGR of 17.37% during the forecast period of 2019-2027 and generate $xx million by the end of 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. The growing prevalence of such chronic diseases, increasing elderly population, unmet medical attention, and the rise in public awareness are the major drivers for the hyperphosphatemia drugs market in this region. The Asia-Pacific regions are expected to further propel the growth of the market in the coming years.

Market Insights

Increased cases of osteoporosis in the ageing population are observed in the Asia-Pacific regions, which are mostly going undertreated and underdiagnosed. This lapse is majorly responsible for the demand of the hyperphosphatemia drugs market in the Asian countries. The Indian hyperphosphatemia drugs market is growing with the highest CAGR of xx% during the forecast period. Growing elderly population in India is the key driving factor responsible for increasing the demand of the hyperphosphatemia drugs market in this region. The hyperphosphatemia drug market is segmented on the basis of the drug formulation. They include iron-based phosphate binders, calcium-based phosphate binders, magnesium-based phosphate binders, aluminium-based phosphate binders, and other phosphate binders. The Calcium-based phosphate binder's formulation is expected to lead the hyperphosphatemia drugs market during the forecast years. The Aluminium-based phosphate binders generated a revenue of $xx million in 2018 and are widely being used for the treatment of hyperphosphatemia in dialysis patients. The magnesium-based phosphorus binders are another widely used phosphorus binders, which also are remarkably being engaged in curing the hyperphosphatemia conditions in all the dialysis patients.

Competitive Insights

The major players in the hyperphosphatemia drug market are Johnson And Johnson, Cipla, Dsm, Biotech Pharmacal, Sun Pharm Inc, Zeria Pharmaceutical, Ultragenyx, Bruno Farmaceutici Spa, Fermenta Biotech Ltd, Fresenius Medical Care Pfizer Inc, Roche Diagnostics Corporation, Keryx Biopharmaceuticals , R.H. Moore Drug Co, Vifor Pharma, Sanofi, and Amag Pharmaceuticals.

Asia Pacific Hyperphosphatemia Drug Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Iron-Based Hyperphosphatemia Drugs Is A Game Changer
4. Market Determinants
4.1. Market Scope & Definition
4.2. Drivers
4.2.1. Growing Prevalence of Chronic Diseases
4.2.2. Unmet Medical Needs
4.2.3. Skewed Population Mix Towards Elderly People
4.2.4. Rise In Public Awareness
4.3. Restraints
4.3.1. Limitations Levied By The Food And Drug Administration (Fda)
4.3.2. Growing Side Effects of The Hyperphosphatemia Drugs
4.4. Challenges
4.4.1. Non-Adherence To Treatment Regimens
4.4.2. Side Effects of Drugs
4.4.3. Limited Availability of Drugs
4.4.4. Use of Advanced Dialysis Techniques
4.5. Market By Dosage
4.5.1. Solid
4.5.1.1. Tablet
4.5.1.2. Powder
4.5.2. Liquid
4.5.2.1. Solution
5. Market By Formulation
5.1.1. Calcium-Based Phosphate Binders
5.1.2. Aluminum-Based Phosphate Binders
5.1.3. Magnesium-Based Phosphate Binders
5.1.4. Iron-Based Phosphate Binders
5.1.5. Other Phosphate Binders
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Bargaining Power of Buyers
6.1.3. Bargaining Power of Suppliers
6.1.4. Threat of Substitute Product
6.1.5. Intensity of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Application
6.3.2. Pricing
6.3.3. Effectiveness
6.3.4. Availability
6.4. Strategic Recommendation & Strategic Conclusions
6.5. Market Trends
6.5.1. Patient Assistance Programs
6.5.2. Strategic Alliances
6.5.3. Increase In R&D
6.6. Phosphate Binders Usages Guidelines
7. Geographic Analysis
7.1. Asia Pacific
7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. Australia
7.1.5. South Korea
7.1.6. Rest of Apac
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Amag Pharmaceuticals
8.2.1.1. Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Biotech Pharmacal
8.2.2.1. Overview
8.2.2.2. Products Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bruno Farmaceutici Spa
8.2.3.1. Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Cipla
8.2.4.1. Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Fermenta Biotech Ltd
8.2.5.1. Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Fresenius Medical Care
8.2.6.1. Overview
8.2.6.2. Product Portfolio
8.2.6.3. Scot Analysis
8.2.6.4. Strategic Initiatives
8.2.7. Johnson And Johnson
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Keryx Biopharmaceuticals Inc
8.2.8.1. Overview
8.2.8.2. Scot Analysis
8.2.8.3. Strategic Initiatives
8.2.9. Pfizer Inc.
8.2.9.1. Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Roche Diagnostics Corporation
8.2.10.1. Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Royal Dsm N.V.
8.2.11.1. Overview
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Sanofi
8.2.12.1. Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Shire
8.2.13.1. Overview
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Sun Pharmaceutical Industries Ltd
8.2.14.1. Overview
8.2.14.2. Products Portfolio
8.2.14.3. Scot Analysis
8.2.14.4. Strategic Initiatives
8.2.15. Ultragenyx Pharmaceutical Inc.
8.2.15.1. Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
8.2.16. Zeria Pharmaceutical
8.2.16.1. Overview
8.2.16.2. Product Portfolio
8.2.16.3. Scot Analysis
8.2.16.4. Strategic Initiatives

List of Tables

Table 1 Asia Pacific Hyperphosphatemia Drug Market 2019-2027($ Million)
Table 2 Iron-Based Hyperphosphatemia Drug Approval Status 2014-2017
Table 3 Worldwide Population Aged 80 And Above 1950-2050 (Millions)
Table 4 Phosphorous Levels In Select Foods
Table 5 Asia Pacific Hyperphosphatemia Drugs Market By Formulation 2019-2027($ Million)
Table 6 Asia Pacific Calcium-Based Phosphate Binders 2019-2027($ Million)
Table 7 Asia Pacific Aluminum-Based Phosphate Binders 2019-2027($ Million)
Table 8 Asia Pacific Magnesium-Based Phosphate Binders 2019-2027($ Million)
Table 9 Asia Pacific Iron-Based Phosphate Binders 2019-2027($ Million)
Table 10 Asia Pacific Other Phosphate Binders 2019-2027($ Million)
Table 11 Pipeline Portfolio of Hyperphosphatemia Drugs
Table 12 Asia Pacific Hyperphosphatemia Drugs Market 2019-2027 ($ Million)
Table 13 Asia-Pacific Hyperphosphatemia Drugs Market By Country 2019-2027($ Million)
Table 14 Per Capita Consumption of Dairy Products In Australia 2014 -2016

List of Figures

Figure 1 Rate of Adherence To Phosphate Binders
Figure 2 Diagnosis And Clinical Indicators of Chronic Kidney Disease
Figure 3 Asia Pacific Hyperphosphatemia Drugs Market By Calcium-Based Phosphate Binders 2019-2027($ Million)
Figure 4 Asia Pacific Hyperphosphatemia Drugs Market By Aluminum-Based Phosphate Binders 2019-2027($ Million)
Figure 5 Asia Pacific Hyperphosphatemia Drugs Market By Magnesium-Based Phosphate Binders 2019-2027($ Million)
Figure 6 Asia Pacific Hyperphosphatemia Drugs Market By Iron-Based Phosphate Binders 2019-2027($ Million)
Figure 7 Asia Pacific Hyperphosphatemia Drugs Market By Other Phosphate Binders 2019-2027($ Million)
Figure 8 Porters 5 Force Model of Hyperphosphatemia Market
Figure 9 Asia-Pacific Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 10 Age Wise Distribution of Elderly Population In India 2016
Figure 11 India Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 12 China Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 13 Japan Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 14 Number of Fractures Due To Osteoporosis And Osteopenia ($ Million)
Figure 15 Australia Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 16 South Korea Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 17 Roapac Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 18 Market Share Analysis of Key Players 2017 (%)
  • Oxycodone Hydrochloride Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Feb-2019        Price: US 3000 Onwards        Pages: 135
    Oxycodone Hydrochloride Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oxycodone Hydrochloride industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oxycodone Hydrochloride manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Ch......
  • Global DNA Vaccines Sales Market Report 2019
    Published: 18-Feb-2019        Price: US 4000 Onwards        Pages: 160
    This report studies the global DNA Vaccines market status and forecast, categorizes the global DNA Vaccines market size (value & volume) by Key Companies, type, application, and region. This report focuses on the top players in United States, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In the last several years, Europe market of DNA Vaccine developed rapidly, with an average growth rate of 9.3%. In 2017, global sale......
  • Global Argatroban Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Feb-2019        Price: US 3480 Onwards        Pages: 121
    Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35. ......
  • Global Lactulose Market Growth 2019-2024
    Published: 18-Feb-2019        Price: US 3660 Onwards        Pages: 137
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Lactulose industry is concentrated relatively and is technology intensive industry. Currently, there are......
  • Oral Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Feb-2019        Price: US 3000 Onwards        Pages: 146
    Oral Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oral Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oral Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Oral Vaccine market coverin......
  • Global Inhalation & Nasal Spray Generic Drugs Market Growth 2019-2024
    Published: 18-Feb-2019        Price: US 3660 Onwards        Pages: 163
    Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Market competition is intense among the top 4. The sales of generic inhalers and nasal sprays is expected to increase even further after the release of studies that point to an increase in the number of patients suffering from restrictive and even life-threatening respiratory diseases, such as COPD and asthma. The incredibly high ......
  • Global Subcutaneous Immunoglobulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Feb-2019        Price: US 3480 Onwards        Pages: 103
    Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump). Scope of the Report: The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 20......
  • Global Thin Film Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Feb-2019        Price: US 3480 Onwards        Pages: 138
    Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Scope of the Report: The classification of Thin Film Drugs includes transdermal film, oral thin film and other types, and the propor......
  • Organ Transplant Immunosuppressant Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Feb-2019        Price: US 3000 Onwards        Pages: 150
    Organ Transplant Immunosuppressant Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Organ Transplant Immunosuppressant industry with a focus on the Chinese market. The report provides key statistics on the market status of the Organ Transplant Immunosuppressant manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs